In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report. Conditions such as alopecia (hair loss), psoriasis, vitiligo (white skin patches), vasculitis (inflammation of blood vessels), Crohn's disease, ulcerative...
In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report.
"Our findings highlight a significant association between SARS-CoV-2 infection and the development of autoimmune and auto-inflammatory disorders. This emphasizes the need for a comprehensive medical approach that encompasses both the acute manifestations and potential long-term complications of COVID-19," said lead researcher Dr. Sung Ha Lim, from the department of dermatology at Yonsei University's Wonju College of Medicine in South Korea.
"It is likely because when you defend yourself against COVID, interferons are produced which trigger inflammation, which can then trigger auto-antibodies against the body's organs, muscles or nerves, especially when you have a tendency towards that disease in the first place," Siegel noted. "Unvaccinated individuals exhibited a greater risk for certain autoimmune diseases, including alopecia areata, alopecia totalis and Crohn's disease," she said.Another expert isn't surprised that COVID-19 can trigger autoimmune diseases.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID Might Raise Odds for Immune Disorders Like Crohn's, AlopeciaTUESDAY, Oct. 10, 2023 (HealthDay News) -- In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report.
Read more »
Getting More Sleep Lowers Risk for Long COVIDOne way to help lower the odds for long COVID in people with pre-existing conditions may be to get more sleep. A new study discovered the risk was lower in those who slept six to nine hours a night compared to 'short sleepers' who snoozed less. 'Habitual short nighttime sleep...
Read more »
Paxlovid Tied to Benefits in High-Risk Patients With COVIDThe use of nirmatrelvir–ritonavir (Paxlovid) is associated with a lower risk for death or hospitalization in extremely vulnerable patients with COVID-19. Low-risk patients do not appear to benefit.
Read more »
Cancer drug restores immune system's ability to fight tumorsCancers that have a deletion in the 9p21 section of their genomes tend to have worse outcomes for patients and increased resistance to immunotherapy. A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer. In mouse models of melanoma, bladder cancer, leukemia and colon cancer, the drug slows the growth of tumors, extends lifespan and boosts the efficacy of immunotherapy.
Read more »
Hancock increases Liontown stakeUnlisted Hancock Prospecting’s stake in lithium developer Liontown Resources reached 16.7% at the end of last week, with the company saying it had paid no more than A$3 a share. Hancock was now Liontown’s largest shareholder and said in a statement that it welcomed the opportunity to participate in Liontown’s Kathleen Valley project as a shareholder, and to have an influence on the company’s overall future direction.
Read more »
Shiba Inu Eyes Explosive 353% Surge in Large Transactions Worth 2.6 Trillion SHIBLarge transactions with Shiba Inu token eye 2.6 trillion SHIB recovery as whale activity increases
Read more »